SignatureFD’s Lifecore Biomedical LFCR Stock Holding History

SignatureFD’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-349	Closed	-$4K	–	3243
2022 Q1	$4K	Buy	349 +202	+137%	+$2.25K	﹤0.01%	2595
2021 Q4	$2K	Buy	+147	New	+$1.43K	﹤0.01%	2750
2021 Q3	–	Sell	-372	Closed	-$4K	–	3138
2021 Q2	$4K	Buy	372 +128	+52%	+$1.48K	﹤0.01%	2357
2021 Q1	$3K	Sell	244 -2	-0.8%	-$22	﹤0.01%	2351
2020 Q4	$3K	Hold	246	–	–	﹤0.01%	2148
2020 Q3	$2K	Sell	246 -428	-64%	-$4.08K	﹤0.01%	2231
2020 Q2	$5K	Buy	+674	New	+$6.95K	﹤0.01%	1812

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SignatureFD's LFCR Position: Q2 2022 in Review

SignatureFD sold out of Lifecore Biomedical (LFCR) in Q2 2022, closing a stake of 349 shares — an estimated $4K sold.

SignatureFD first reported a position in LFCR in Q2 2020 and held it in 7 quarters. The position peaked at $5K in Q2 2020. 90 funds tracked by Wall St. Rank hold LFCR as of Q2 2022.

SignatureFD reported no remaining Lifecore Biomedical position as of Q2 2022 after selling out during the quarter.
SignatureFD sold 349 Lifecore Biomedical shares in Q2 2022, an estimated $4K.
SignatureFD first reported a position in Lifecore Biomedical in Q2 2020 and held it in 7 quarters.
SignatureFD's Lifecore Biomedical position peaked at $5K in Q2 2020.
90 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2022.

Based on SignatureFD's 13F filing for Q2 2022, filed 10 Aug 2022.